A growing problem of interest in the field of science and technology policy is that the next generation of innovations is arriving at an accelerating rate, and the governance system is struggling to catch up. Current approaches and institutions for effective technology assessment are ill suited and poorly designed to proactively address the multidimensional, interconnected societal impacts of science and technology advancements that are already taking place and expected to continue over the course of the 21st century. This book offers tangible insights into the strategies deployed by well-known, high-profile organizations involved in anticipating the various societal and policy implications of nanotechnology and synthetic biology. It focuses predominantly on an examination of the practices adopted by the often-cited and uniquely positioned Project on Emerging Nanotechnologies in the United States, as well as being informed by comparisons with a range of institutions also interested in embedding forward-looking perspectives in their respective area of innovation. The book lays out one of the first actionable roadmaps that other interested stakeholders can follow when working toward institutionalizing anticipatory governance practices throughout the policymaking process.

This review addresses Korea’s industry and technology policies and institutions, and provides policy recommendations.

Policies to spur innovative medical breakthroughs from laboratories to patients : hearing before the Subcommittee on Research and Technology, Committee on Science, Space, and Technology, House of Representatives, One Hundred Thirteenth Congress, second session, July 17, 2014.